Reports for TEVA-CANDESARTAN/HCTZ
Brand name TEVA-CANDESARTAN/HCTZ |
|---|
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02395541 |
Ingredients
HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL |
Ingredient Strength
12.5 MG 16 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-CANDESARTAN/HCTZ | 30 | Resolved | 2019-06-18 | 2020-04-23 | 86963 |
| TEVA-CANDESARTAN/HCTZ | P/P 30 | Resolved | 2021-10-21 | 2022-01-07 | 147702 |
| TEVA-CANDESARTAN/HCTZ | PP | Actual shortage | 2024-09-19 | 2025-05-02 | 237989 |
Showing 1 to 3 of 3
Discontinuation reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0